Top

Published in:

01-03-2017

Cervical Cancer Prevention in Malaysia: Knowledge and Attitude of Undergraduate Pharmacy Students Towards Human Papillomavirus Infection, Screening and Vaccination in Malaysia

Authors: Mari Kannan Maharajan, Kingston Rajiah, Kelly Num Sze Fang, Lai Yun Lui

Published in: Journal of Cancer Education | Issue 1/2017

Abstract

This study was conducted to evaluate knowledge of undergraduate pharmacy students about human papillomavirus infection and their attitude towards its prevention. A cross-sectional survey was conducted in 270 undergraduate pharmacy students using a validated questionnaire to assess knowledge about human papillomavirus infection and cervical cancer and their attitudes towards human papillomavirus vaccines. Eighty-one percent of the respondents knew that human papillomavirus is a cause of cervical cancer, and 87.8 % knew that this infection is preventable. The gender of the respondents showed the strongest correlations with human papillomavirus knowledge. There were no significant correlations between the ethnic group of the respondents and their human papillomavirus-related knowledge. Higher perceptions of risk were associated with relationship status, and respondents who were in a relationship showed greater interest in vaccinating themselves; relationship status emerged as a unique predictor. The results indicated a moderately high level of knowledge and positive attitude towards human papillomavirus vaccination with few disagreements. The results of this study will help to develop and plan appropriate education campaigns for pharmacy students that aim to reduce human papillomavirus infection and, consequently, the incidence of and mortality caused by cervical cancer in Malaysia.

Lu M, Moritz S, Lorenzetti D, Sykes L, Straus S, Quan H (2012) A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. BMC Public Health 12:413CrossRefPubMedPubMedCentral

Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621–632CrossRefPubMed

Bruni L, Barrionuevo-Rosas L, Albero G et al (2015) ICO Information Centre on HPV and cancer (HPV Information Centre). Human papillomavirus and related diseases in Malaysia. Summary report 2015-03-20 [Data accessed].

Van Kriekinge G, Castellsagué X, Cibula D, Demarteau N (2014) Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths. Vaccine 32:733–739CrossRefPubMed

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC.

Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed 15 Jan 2014

Zaridah S (2014) A review of cervical cancer research in Malaysia. Med J Malaysia 69:33–41PubMed

Donati S, Giambi C, Declich S, Salmaso S, Filia A, Atti M et al (2012) Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women. Vaccine 30:2075–2082

Liddon N, Hood J, Wynn BA, Markowitz LE (2010) Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health 46:113–123CrossRefPubMed

10.

Rashwan HH, Saat NZ, Abd Manan DN (2012) Knowledge attitude and practice of Malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev 13:2279–2283CrossRefPubMed

11.

Wong S (2001) Pharmacy practice in Malaysia. Malaysian J Pharmacy 1:2–8

12.

Wong LP, Sam IC (2010) Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol 148:90–95CrossRefPubMed

13.

Giles M, Garland S (2006) A study of women’s knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. Aust N Z J Obstet Gynaecol 46:311–315CrossRefPubMed

14.

Philips Z, Johnson S, Avis M, Whynes DK (2003) Human papillomavirus and the value of screening: young women’s knowledge of cervical cancer. Health Educ Res 18:318–328CrossRefPubMed

15.

Ankur B (2013) Methods for decision-making in survey questionnaires with continuous variables. Education Res J 3:47–49

16.

Ankur B (2013) Methods for decision-making in survey questionnaires based on Likert scale. J Asian Scientific Res 3:35–38

17.

Somba MJ, Mbonile M, Obure J, Mahande MJ (2014) Sexual behavior, contraceptive knowledge and use among female undergraduates’ students of Muhimbili and Dar es Salaam Universities, Tanzania: a cross-sectional study. BMC Womens Health 14:94CrossRefPubMedPubMedCentral

18.

Tortolero-Luna G, Finney Rutten LJ, Hesse BW et al (2010) Health and cancer information seeking practices and preferences in Puerto Rico: creating an evidence base for cancer communication efforts. J Health Commun 15:30–45

19.

Gamble HL, Klosky JL, Parra GR, Randolph ME (2010) Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol 35:704–715CrossRefPubMed

20.

James C, James N, Davies D, Harvey P, Tweddle S (1999) Preferences for different sources of information about cancer. Patient Educ Couns 37:273–282CrossRefPubMed

21.

Griffioen AM, Glynn S, Mullins TK, Zimet GD et al (2012) Perspectives on decision making about human papillomavirus vaccination among 11- to 12-year-old girls and their mothers. Clin Pediatr (Phila) 51:560–568

22.

Bodemer N, Müller SM, Okan Y, Garcia-Retamero R, Neumeyer-Gromen A (2012) Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine. Vaccine 30:3747–3756CrossRefPubMed

23.

Fortuna RJ, Robbins BW, Halterman JS (2009) Ambulatory care among young adults in the United States. Ann Intern Med 151(6):379–385CrossRefPubMed

24.

Strohl AE, Mendoza G, Ghant MS, Cameron KA, Simon MA, Schink JC, Marsh EE (2015) Barriers to prevention: knowledge of HPV cervical cancer and HPV vaccinations among African American women. Am J Obstet Gynecol 212(1):65.e1–5CrossRef

25.

Patel DA, Zochowski M, Peterman S, Dempsey AF, Ernst S, Dalton VK (2012) Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health 60(2):151–161CrossRefPubMedPubMedCentral

26.

Wetzel C, Tissot A, Kollar LM, Hillard PA, Stone R, Kahn JA (2007) Development of an HPV educational protocol for adolescents. J Pediatr Adolesc Gynecol 20(5):281–287CrossRefPubMedPubMedCentral

27.

Thanapprapasr D, Chittithaworn S, Lertkhachonsuk AA, Udomsubpayakul U, Wilailak S (2010) Female hospital-based healthcare professionals’ knowledge of cervical cancer HPV and attitudes towards HPV vaccination. Asian Pac J Cancer Prev 11:429–433PubMed

28.

Wong LP (2010) Role of men in promoting the uptake of HPV vaccinations: focus groups’ finding from a developing country. Int J Public Health 55:35–42CrossRefPubMed

29.

Mays RM, Zimet GD, Winston Y et al (2000) Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Intl 21:361

30.

Wilson RJ, Paterson P, Jarrett C, Larson HJ (2015) Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. doi:10.1016/j.vaccine.2015.08.046

31.

Wong LP (2008) Young multiethnic women’s attitudes toward the HPV vaccine and HPV vaccination. Int J Gynecol Obstet 103:131–135CrossRef

32.

Dinas K, Nasioutziki M, Arvanitidou O, Mavromatidis G, Loufopoulos P, Pantazis K et al (2009) Awareness of human papillomavirus infection, testing and vaccination in midwives and midwifery students in Greece. J Obstet Gynaecol 29:542–546

33.

Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B (2006) Psychosocial aspects of vaccine acceptability. Vaccine 24:S3/201–209CrossRef

34.

Allen JD, Coronado GD, Williams RS et al (2010) A systematic review of measures used in studies of human papillomavirus HPV vaccine acceptability. Vaccine 28:4027–4037CrossRefPubMedPubMedCentral

35.

Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L (2009) Human papillomavirus HPV awareness and vaccination initiation among women in the United States National Immunization Survey-Adult 2007. Prev Med 48:426–431CrossRefPubMed

36.

Gerend MA, Magloire ZF (2008) Awareness knowledge and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 42:237–242CrossRefPubMed

37.

Eaton L, Kalichman S, Cain D, Cherry C, Pope H, Fuhrel A, Kaufman M (2008) Perceived prevalence and risks for human papillomavirus (HPV) infection among women who have sex with women. J Womens Health (Larchmt) 17:75–83CrossRef

38.

Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S (2014) Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 168:76–82CrossRefPubMedPubMedCentral

39.

Wong LP (2011) Issues surrounding HPV vaccine delivery in a multi-ethnic country in Asia: the physician’s perspective. J Community Health 36:14–22CrossRefPubMed

40.

Wong LP, Sam IC (2007) Current issues facing the introduction of human papillomavirus vaccine in Malaysia. Malaysian Fam Physician 2:47–53

Title: Cervical Cancer Prevention in Malaysia: Knowledge and Attitude of Undergraduate Pharmacy Students Towards Human Papillomavirus Infection, Screening and Vaccination in Malaysia
Authors: Mari Kannan Maharajan
Kingston Rajiah
Kelly Num Sze Fang
Lai Yun Lui
Publication date: 01-03-2017
Publisher: Springer US
Published in: Journal of Cancer Education / Issue 1/2017
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-015-0957-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

The National Cancer Institute R25 Cancer Education Grants Program: A Workshop Report

Georgia Primary Care Providers’ Knowledge of Hereditary Breast and Ovarian Cancer Syndrome

Messages of Hope: Helping Family Members to Overcome Fears and Fatalistic Attitudes Toward Cancer

Stress In An Oncologist’s Life: Present But Not Insurmountable

Barriers and Challenges of Cancer Patients and Their Experience with Patient Navigators in the Rural US/Mexico Border Region

Breast Cancer Survivor Advocacy at a University Hospital: Development of a Peer Support Program with Evaluation by Patients, Advocates, and Clinicians

Keynote webinar | Spotlight on antibody–drug conjugates in cancer